| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H19NS |
| Molecular Weight | 293.426 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCC(CC1)=C2C3=C(SC4=C2C=CC=C4)C=CC=C3
InChI
InChIKey=NZLVRVYNQYGMAB-UHFFFAOYSA-N
InChI=1S/C19H19NS/c1-20-12-10-14(11-13-20)19-15-6-2-4-8-17(15)21-18-9-5-3-7-16(18)19/h2-9H,10-13H2,1H3
| Molecular Formula | C19H19NS |
| Molecular Weight | 293.426 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
CNS Activity
Approval Year
PubMed
Patents
Sample Use Guides
Children from 24 to 30 months: 2 to 3 dosing cups (graduation at 5 ml) distributed over the day,
Children from 30 months to 5 years: 3 to 4 dosing cups (graduation at 5 ml) distributed over the day,
Children from 5 to 15 years: 5 to 6 dosing cups (graduation at 5 ml) distributed over the day.
The strongest dose will be kept for the evening due to the possibility of drowsiness related with this
medicine
Route of Administration:
Oral
